Biologics Beyond Boundaries.

Developing first-in-class therapeutics to treat
brain cancers and CNS diseases.
contact us
With a goal to extend the reach of biological therapeutics to the brain to tackle CNS diseases head-on, Nanocarry is pioneering a multidisciplinary approach that enables biologics to access the brain, overcoming the Blood Brain Barrier (BBB).

The Challenge

Our proprietary technology platform’s Plug & Play approach offers infinite possibilities. The rise of biologics over the last 20 years has revolutionized disease treatment; however, 1 in 6 people worldwide are living with a neurological condition and patients with brain diseases are being left behind, as existing therapeutics cannot access the brain, due to the restrictive Blood-Brain Barrier (BBB). Read More

98%

of all drugs are
brain excluded

1 vs. 100

While ~100 antibodies are approved
for various indications, only 1 antibody
is approved for CNS disease.

<0.01%

of an injected dose of a
therapeutic antibody is
delivered to the brain

One core technology,

infinite possibilities.

AXS Technology Platform

50-fold increase in brain delivery of antibody’s injected dose, with 8x the payload.

Our proprietary technology platform’s Plug & Play approach opens the doors to infinite possibilities to create novel therapeutics with optimal modalities and mechanisms of action, for the treatment of brain cancers and CNS diseases.

About AXS

The Platform
In Action

We are currently developing an in-house neuro-oncology pipeline for brain metastases of breast and lung cancers and are seeking partnerships to co-develop the next generation of therapeutics for patients living with neurodegenerative diseases and genetic diseases of the CNS.
Our Pipeline

Our Latest News

We are excited to be presenting at this year's BIO Europe Conference

We are excited to be presenting at this year's BIO Europe Conference

We are proud to have been chosen to receive NFX FAST Pre-Seed & Seed Funding

We are proud to have been chosen to receive NFX FAST Pre-Seed & Seed Funding

Nanocarry is excited to be presenting at the upcoming LSX Inve$tival Showcase!

Nanocarry is excited to be presenting at the upcoming LSX Inve$tival Showcase!

Contact Us

To find out more please leave your email:

Lab & Headquarters
3 Pinhas Sapir Street
Weizmann Science Park , IL

Linkedin
© 2022 Nanocarry Therapeutics, all rights reserved.

designed by Studio7Design

Skip to content